X4 Pharmaceuticals
(NASDAQ:XFOR)
$1.1401
-0.0099[-0.86%]
Last update: 9:28AM Get Real Time Here
Q1 2024 earnings tomorrow on Tue May 7th before the market open
Conference call scheduled tomorrow at 8:30 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

X4 Pharmaceuticals Stock (NASDAQ:XFOR), Quotes and News Summary

X4 Pharmaceuticals Stock (NASDAQ: XFOR) stock price, news, charts, stock research, profile.

Open$1.150
Close-
Volume / Avg.1.785M / 3.084M
Day Range1.105 - 1.190
52 Wk Range0.572 - 2.575
Market Cap$191.466M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
7.41%
Days to Cover2.21

Recent News

FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder
FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare immunodeficiency disorder. Potential sales forecasted at $54.6M in 2024, rising to $450.9M by 2027.
Vandana Singh
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.
Avi Kapoor
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
XFOR
OTLK

FAQ

Q

How do I buy X4 Pharmaceuticals (XFOR) stock?

A

You can purchase shares of X4 Pharmaceuticals (NASDAQ: XFOR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are X4 Pharmaceuticals's (XFOR) competitors?

A

Other companies in X4 Pharmaceuticals’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).

Q

What is the target price for X4 Pharmaceuticals (XFOR) stock?

A

The latest price target for X4 Pharmaceuticals (NASDAQ: XFOR) was reported by HC Wainwright & Co. on Tuesday, April 30, 2024. The analyst firm set a price target for 5.00 expecting XFOR to rise to within 12 months (a possible 332.90% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for X4 Pharmaceuticals (XFOR)?

A

The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $1.155 last updated Today at May 6, 2024 at 1:22 PM EDT.

Q

Does X4 Pharmaceuticals (XFOR) pay a dividend?

A

There are no upcoming dividends for X4 Pharmaceuticals.

Q

When is X4 Pharmaceuticals (NASDAQ:XFOR) reporting earnings?

A

X4 Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is X4 Pharmaceuticals (XFOR) going to split?

A

There is no upcoming split for X4 Pharmaceuticals.

Q

What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

A

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch